Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-02-10 @ 11:41 AM
Study NCT ID:
NCT00129766
Status:
COMPLETED
Last Update Posted:
2013-08-28
First Post:
2005-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children
Sponsor:
Organization: